Verum Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $643K | Buy |
3,465
+670
| +24% | +$124K | 0.15% | 79 |
|
|
2025
Q1 | $586K | Sell |
2,795
-89
| -3% | -$18.6K | 0.16% | 72 |
|
|
2024
Q4 | $513K | Sell |
2,884
-82
| -3% | -$14.6K | 0.15% | 87 |
|
|
2024
Q3 | $586K | Buy |
2,966
+185
| +7% | +$36.5K | 0.17% | 77 |
|
|
2024
Q2 | $477K | Sell |
2,781
-2
| -0.1% | -$343 | 0.15% | 82 |
|
|
2024
Q1 | $507K | Sell |
2,783
-115
| -4% | -$20.9K | 0.18% | 83 |
|
|
2023
Q4 | $449K | Sell |
2,898
-33
| -1% | -$5.12K | 0.18% | 83 |
|
|
2023
Q3 | $437K | Buy |
2,931
+1,017
| +53% | +$152K | 0.2% | 80 |
|
|
2023
Q2 | $258K | Buy |
+1,914
| New | +$258K | 0.23% | 74 |
|